NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• Hematopoietic Cell Transplantation (HCT) is a potentially curative treatment for malignancies.
• Recurrent disease and transplant complications impact long-term survival in HCT recipients.

Purpose of the Study:

• To provide evidence- and consensus-based guidance on autologous and allogeneic HCT for adult malignancies.
• To update clinicians and patients on recent advancements in HCT management.
• To incorporate new principles of conditioning for HCT.

Main Methods:

• Development of evidence- and consensus-based guidelines.
• Review and incorporation of recent updates and new sections.
• Focus on pretransplant evaluation, cell mobilization, and graft-versus-host disease management.

Main Results:

• The NCCN Guidelines for HCT offer a comprehensive approach to managing malignant diseases.
• Recent updates include a new section on Principles of Conditioning for HCT.
• Guidance covers critical aspects from patient evaluation to complication management.

Conclusions:

• The updated NCCN Guidelines for HCT aim to optimize patient and clinician decision-making.
• These guidelines support the effective use of HCT for malignant diseases.
• Addressing complications like graft-versus-host disease is crucial for improving HCT outcomes.